International Stem Cell Management
Management criteria checks 4/4
International Stem Cell's CEO is Andrey Semechkin, appointed in Nov 2009, has a tenure of 14.58 years. total yearly compensation is $112.87K, comprised of 59% salary and 41% bonuses, including company stock and options. directly owns 53.3% of the company’s shares, worth $362.64K. The average tenure of the management team and the board of directors is 11 years and 15.7 years respectively.
Key information
Andrey Semechkin
Chief executive officer
US$112.9k
Total compensation
| CEO salary percentage | 59.0% |
| CEO tenure | 14.6yrs |
| CEO ownership | 53.3% |
| Management average tenure | 11yrs |
| Board average tenure | 15.7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$311k |
| Dec 31 2023 | US$113k | US$67k | -US$131k |
| Sep 30 2023 | n/a | n/a | US$195k |
| Jun 30 2023 | n/a | n/a | -US$79k |
| Mar 31 2023 | n/a | n/a | -US$356k |
| Dec 31 2022 | US$396k | US$63k | -US$331k |
| Sep 30 2022 | n/a | n/a | -US$705k |
| Jun 30 2022 | n/a | n/a | -US$527k |
| Mar 31 2022 | n/a | n/a | -US$309k |
| Dec 31 2021 | US$126k | US$58k | -US$899k |
| Sep 30 2021 | n/a | n/a | -US$1m |
| Jun 30 2021 | n/a | n/a | -US$2m |
| Mar 31 2021 | n/a | n/a | -US$3m |
| Dec 31 2020 | US$54k | US$54k | -US$3m |
| Sep 30 2020 | n/a | n/a | -US$5m |
| Jun 30 2020 | n/a | n/a | -US$4m |
| Mar 31 2020 | n/a | n/a | -US$4m |
| Dec 31 2019 | US$201k | US$44k | -US$4m |
| Sep 30 2019 | n/a | n/a | -US$3m |
| Jun 30 2019 | n/a | n/a | -US$2m |
| Mar 31 2019 | n/a | n/a | -US$2m |
| Dec 31 2018 | US$420k | US$48k | -US$2m |
| Sep 30 2018 | n/a | n/a | -US$2m |
| Jun 30 2018 | n/a | n/a | -US$5m |
| Mar 31 2018 | n/a | n/a | -US$4m |
| Dec 31 2017 | US$243k | US$102k | -US$6m |
Compensation vs Market: Andrey's total compensation ($USD112.87K) is below average for companies of similar size in the US market ($USD689.64K).
Compensation vs Earnings: Andrey's compensation has been consistent with company performance over the past year.
CEO
Andrey Semechkin (64 yo)
14.6yrs
Tenure
US$112,865
Compensation
Prof. Dr. Andrey Semechkin, Ph D., has been the Chief Executive Officer of International Stem Cell Corporation since November 15, 2009 and has been its Co-Chairman of the Board since October 6, 2011 and ha...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Chairman of the Board & CEO | 14.6yrs | US$112.87k | 53.3% $ 362.6k | |
| Executive VP | 11yrs | US$377.24k | 0% $ 0 | |
| President of Lifeline Cell Technology | 2.4yrs | no data | no data |
11.0yrs
Average Tenure
Experienced Management: ISCO's management team is seasoned and experienced (11 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Chairman of the Board & CEO | 15.5yrs | US$112.87k | 53.3% $ 362.6k | |
| Executive VP | 15.7yrs | US$377.24k | 0% $ 0 | |
| Independent Director | 16.9yrs | US$81.67k | 0.41% $ 2.8k | |
| Co-Founder & Chairman Emeritus | 12.3yrs | US$1.32m | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Co-Chairman of the Board | 17.3yrs | US$96.67k | 0.059% $ 402.8 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
15.7yrs
Average Tenure
72yo
Average Age
Experienced Board: ISCO's board of directors are seasoned and experienced ( 15.7 years average tenure).